[EXPERT REACTION] What is the difference between VOI & VOC?

Recently, Malaysia has been recording an increased number of COVID-19 cases categorised by either the Variant of Concern (VOC) or Variant of Interest (VOI). VOCs or VOIs are mutant forms of the COVID virus (SARS-CoV-2), which are more virulent and infectious than its predecessor Wuhan strain. Dr Liyana explains the difference between VOI and VOCs in Malaysia.

[OPINION] Opportunity Knocks: How We Can Turn the Tide of Covid-19 Transmission in Malaysia

The 3rd iteration of the Movement Control Order (MCO) has just been intensified. It is as such an opportune time for us to take cognizance of our control measures so far and in doing so realign our response measures to COVID-19. Dr Dhesi BR in his opinion piece presents six key priority areas within which said realignment must take place.

[MEDIA RELEASE] WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.

[OPINION] Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?

As of 12 May 2020, 4,425,094 people have been infected with SARS-CoV-2 with deaths reaching 297,723.Doctors are desperately looking for an effective drug, and there have been a number of candidates on trial; one of them, remdesivir, is probably the most exciting of all. This is the drug developed for the Ebola epidemic in 2015, but it was found to be less effective in clinical trials than in in vitro studies. Is remdesivir the panacea for COVID-19?

[EXPERT REACTION] Dexamethasone: Effective Treatment for COVID-19?

A research team at Oxford University has recently found a cheap and widely available drug called dexamethasone that can be used to effectively treat severe forms of COVID-19. The 'breakthrough' drug has shown to significantly reduce the number of deaths among those seriously ill with the coronavirus. We asked experts to comment on the effectiveness of the drug in treating COVID-19.

[Q&A] Bats, Pangolins and the Coronavirus

While bats have been put forward as the original host of SARS-CoV-2 nonetheless, the transmission of the virus from bats to humans requires intermediate hosts as well. Several studies have linked pangolins with SARS-CoV-2 infection where coronaviruses found in pangolin are highly similar to the novel coronavirus, which suggests that the mammal is the most likely intermediate host.

[MEDIA RELEASE] Stay Vigilant during Recovery MCO – MHC

The Malaysian Health Coalition (MHC) understands and supports the government’s decision to transition into the recovery phase of the movement control order (RMCO). The gradual reopening of public life in Malaysia must rely on appropriate guidance from all areas of government and the Ministry of Health. We must remain vigilant until a vaccine for Covid-19 is available.

[MEDIA RELEASE] Return to Work after the MCO for COVID-19 infection – A Guide for Workplace

A group of academics from the Faculty of Medicine, University of Malaya have developed a guideline for Return to Work after the Movement Control Order (MCO) for COVID-19 infection. The guide covers commonly asked questions such as the need to test employees returning to work after the Movement Control Order (MCO) for COVID-19 infection, available testing methods and how to protect employees and avoid a COVID-19 outbreak at the workplace including the use of technology.

[OPINION] Safety Profile and Specifics of the School Reopening Guidelines Need Strengthening – Consultant Paediatricians

This week the Ministry of Education Malaysia (MOE) released a guideline and standard operating procedure (SOP) regarding school management and measures to control the spread of COVID-19. The guidelines have been endorsed by the Ministry of Health Malaysia (MOH) and the National Security Council (MKN). This guideline covers all schools under MOE as well as the private educational institutions registered with MOE.